This cluster of papers focuses on the use of breast magnetic resonance imaging (MRI) in oncology, particularly in the context of cancer biomarkers, diagnostic accuracy for breast lesions, monitoring tumor response to neoadjuvant chemotherapy, and the application of diffusion-weighted and dynamic contrast-enhanced MRI for assessing perfusion and tumor characteristics. The research also explores the potential of breast MRI as a tool for predicting and monitoring treatment response in breast cancer patients.